ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0084

Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort

Natalia Cabrera1, Vannia Valinotti2, Gabriela Avila-Pedretti1, Sonia Cabrera2, Patricia Melgarejo3, Zoilo Morel4, Lourdes Roman2, Pedro Babak4, Rodrigo Acosta2, Romina Glitz4, Darwin Cordovilla5, Roger Rolon4, Magali Zanotti-Cavazzoni1, Marco Antonio Franco Britos6, Marcos Vazquez2, Pedro Delgadillo4, Isabel Acosta2, María del Carmen Martinez4, Gabriel Elizaur4, María Teresa Romero4, Ernesto Paredes4, Paloma de Abreu1 and Leticia Segovia7, 1Sociedad Paraguaya de Reumatología, Asunción, Paraguay, 2Hospital de Clínicas, Asunción, Paraguay, 3Hospital IPS, Villa Rica, Paraguay, 4Hospital Central del Instituto de Previsión Social, Asunción, Paraguay, 5Instituto Nacional de Reumatología, Montevideo, Uruguay, 6Instituto de Previsi�n Social, Asunci�n, Central, Paraguay, 7Hospital del IPS, Asunción, Paraguay

Meeting: ACR Convergence 2020

Keywords: Ankylosing spondylitis (AS), Biologicals, Juvenile idiopathic arthritis, Psoriatic arthritis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The Paraguayan-Uruguayan cohort of patients with rheumatic inflammatory diseases (BIOBADAGUAY), collect clinical and epidemiological information on adults and children patients receiving biological therapies (BT). The obtained data enable to describe with comparative purposes the cohort of patients, considering the age of symptom onset (i.e. juvenile or adult)

Methods: BIOBADAGUAY cohort includes 18 centers (9 in Uruguay and 9 in Paraguay). The descriptive analysis was made in two phases. First, we have selected the adult population on BT and second, we have separated it in two groups according onset of disease considering the age when diagnosis of rheumatic disease was made. Clinical features of both populations were described in a second phase

Results: A total of 766 adult patients was included, in which 91,1% had adult-onset, and 8.9% had juvenile-onset rheumatic disease. Female predominance was observed in both adult-onset and juvenile-onset groups (74.1% vs 64.7%, respectively). Mean disease duration was 18.5 ± 11.2 years for juvenile-onset rheumatic disease and 13.1 ± 8.7 years for adult-onset rheumatic disease. Disease activity was similar for both rheumatoid arthritis and spondylarthritis in the two groups. All of juvenile-onset rheumatic disease patiets, did not have a comorbidity when starting a BT. Mean body mass index was 24.9 ± 4.5 for juvenile-onset rheumatic disease and 27.9 ± 6.0 for adult-onset rheumatic disease. Table 1 describes main clinical and epidemiological characteristics of analyzed populations.

Conclusion: Patients with juvenile-onset rheumatic disease present with particular characteristics (disease duration, comorbidities and mean body mass index) that differentiate them from adult-onset rheumatic disease patients. This should be taken into consideration when assessing and follow-up is being made on each patient


Disclosure: N. Cabrera, None; V. Valinotti, None; G. Avila-Pedretti, None; S. Cabrera, None; P. Melgarejo, None; Z. Morel, None; L. Roman, None; P. Babak, None; R. Acosta, None; R. Glitz, None; D. Cordovilla, None; R. Rolon, None; M. Zanotti-Cavazzoni, None; M. Franco Britos, None; M. Vazquez, None; P. Delgadillo, None; I. Acosta, None; M. Martinez, None; G. Elizaur, None; M. Romero, None; E. Paredes, None; P. de Abreu, None; L. Segovia, None.

To cite this abstract in AMA style:

Cabrera N, Valinotti V, Avila-Pedretti G, Cabrera S, Melgarejo P, Morel Z, Roman L, Babak P, Acosta R, Glitz R, Cordovilla D, Rolon R, Zanotti-Cavazzoni M, Franco Britos M, Vazquez M, Delgadillo P, Acosta I, Martinez M, Elizaur G, Romero M, Paredes E, de Abreu P, Segovia L. Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-of-patients-with-rheumatism-of-juvenile-onset-and-adult-onset-in-the-biobadaguay-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-patients-with-rheumatism-of-juvenile-onset-and-adult-onset-in-the-biobadaguay-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology